[Determination of sitagliptin phosphate in rat plasma by ultra high performance liquid chromatography-tandem mass spectrometry]. 2011

Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China.

An ultra high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the determination of sitagliptin phosphate in rat plasma was established. The blank rat plasma sample added with sitagliptin phosphate and the internal standard (fluoxetine) standard solution were prepared. Methanol was added in the sample for the deproteinization. Then the sample was vortex-mixed and centrifuged. The clear supernatant was used for the analysis of UPLC-MS/MS. A Thermo Hypersil Gold C18 column (50 mm x 2.1 mm, 1.9 microm) was employed with a guard column of Phenomenex Security Guard C18 column (4 mm x 3.0 mm), and the column temperature was set at 35 degrees C. The gradient elution of acetonitrile and water (containing 0.05% (v/v) formic acid) as mobile phases was performed at a flow rate of 200 microL/min, and a rapid separation was completed in 5 min. The electrospray was operated in the positive ionization mode and the sitagliptin phosphate and fluoxetine were identified by selected reaction monitoring (SRM) mode, and the monitoring ions of them were m/z 408.0 --> 235.0 and m/z 310.0 --> 148.0, respectively, which were used to qualify and quantity the targets by the method of matrix-matched standard solution. The calibration curve showed good linearity within the concentrations of 1 to 1 000 microg/L (r = 0.999 1); the limit of detection was 0.2 microg/L. The mean recoveries were from 85% to 115% at the spiked levels of 5, 50 and 500 microg/L; the relative standard deviations (RSDs) of intra- and inter-day of variation were both less than 15%, which can meet the determination requirements of biological samples. Then the method was initially used for the determination of sitagliptin phosphate in SD rat plasma after the administration of a single intravenous injection dose of sitagliptin phosphate. The method is rapid, sensitive, convenient and reproducible in the determination of sitagliptin phosphate, and can be used for the pharmacokinetics research of sitagliptin phosphate in plasma.

UI MeSH Term Description Entries
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D000068900 Sitagliptin Phosphate A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine,Januvia,MK 0431,MK-0431,MK0431,Sitagliptin,Sitagliptin Monophosphate Monohydrate,Sitagliptin Phosphate Anhydrous,Sitagliptin Phosphate Monohydrate,0431, MK,Anhydrous, Sitagliptin Phosphate,Monohydrate, Sitagliptin Monophosphate,Monohydrate, Sitagliptin Phosphate,Monophosphate Monohydrate, Sitagliptin,Phosphate Anhydrous, Sitagliptin,Phosphate Monohydrate, Sitagliptin,Phosphate, Sitagliptin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D054873 Dipeptidyl-Peptidase IV Inhibitors Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. DPP-4 Inhibitor,DPP-4 Inhibitors,DPP-IV Inhibitor,DPP-IV Inhibitors,DPP4 Inhibitor,DPP4 Inhibitors,Dipeptidyl Peptidase 4 Inhibitor,Dipeptidyl-Peptidase 4 Inhibitor,Dipeptidyl-Peptidase IV Inhibitor,Gliptin,Gliptins,Dipeptidyl-Peptidase 4 Inhibitors,DPP 4 Inhibitor,DPP 4 Inhibitors,DPP IV Inhibitor,DPP IV Inhibitors,Dipeptidyl Peptidase 4 Inhibitors,Dipeptidyl Peptidase IV Inhibitor,Dipeptidyl Peptidase IV Inhibitors,Inhibitor, DPP-4,Inhibitor, DPP-IV,Inhibitor, DPP4,Inhibitor, Dipeptidyl-Peptidase 4,Inhibitor, Dipeptidyl-Peptidase IV
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass

Related Publications

Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
May 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
December 2019, Se pu = Chinese journal of chromatography,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
August 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
November 2022, Journal of chromatography open,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
January 2013, Journal of analytical toxicology,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
October 2013, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
January 2011, Phytochemical analysis : PCA,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
August 2018, Talanta,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
June 2014, Journal of pharmaceutical analysis,
Yao Tang, and Xiang Li, and Nie Wen, and Xu Sun, and Ling Zhu, and Min Yu, and Zuogang Li, and Bo Li
January 2006, Rapid communications in mass spectrometry : RCM,
Copied contents to your clipboard!